Provides Cardiovascular Benefits (Anti-inflammatory) Clinical trials (e.g., SUSTAIN-6, SELECT) have shown semaglutide reduces the risk of major adverse cardiovascular events (heart attack, stroke, CV death) in people with type 2 diabetes and high cardiovascular risk
Why doubling works as an escalation strategy The dose steps in the retatrutide schedule roughly double at each level: 2mg to 4mg to 8mg, with the final step from 8mg to 12mg being a 50% increase
As always, community anecdote is not data, and none of it changes the Research-Use-Only status of either compound
Peptides like tirzepatide have captured the attention of the global research community, opening up formidable new avenues in metabolic science
- safety data on hair-specific concerns - Does GHK-Cu Cause Liver Damage
At -20C, properly lyophilized CJC-1295 no DAC & Ipamorelin maintain 95%+ purity for 24-36 months